AstraZeneca PLC Stock price

Equities

AZN

GB0009895292

Pharmaceuticals

Delayed London Stock Exchange 11:35:13 2023-09-29 am EDT Intraday chart for AstraZeneca PLC 5-day change 1st Jan Change
11102.00 GBX +0.87% +0.51% -1.03%
Sales 2023 * 45,778 M Sales 2024 * 50,522 M Capitalization 208 B
Net income 2023 * 6,472 M Net income 2024 * 8,899 M EV / Sales 2023 *
5,02x
Net Debt 2023 * 21,552 M Net Debt 2024 * 17,026 M EV / Sales 2024 *
4,46x
P/E ratio 2023 *
29,8x
P/E ratio 2024 *
22,3x
Employees -
Yield 2023 *
2,25%
Yield 2024 *
2,35%
Free-Float96.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.21%
1 week+1.07%
Current month+4.71%
1 month+3.33%
3 months-0.64%
6 months-0.02%
Current year-0.48%
More quotes
1 week
10 878.00
Extreme 10878
11 310.00
1 month
10 366.00
Extreme 10366
11 310.00
Current year
10 020.00
Extreme 10020
12 392.00
1 year
9 499.21
Extreme 9499.2143
12 392.00
3 years
6 736.00
Extreme 6736
12 392.00
5 years
5 312.00
Extreme 5312
12 392.00
10 years
3 106.00
Extreme 3106
12 392.00
More quotes
Date Price Change Volume
23-09-29 11102.00 +0.87% 1 571 473
23-09-28 11006.00 -1.01% 1,491,439
23-09-27 11118.00 -0.41% 1,501,178
23-09-26 11164.00 -0.27% 1,606,820
23-09-25 11194.00 +1.34% 3,471,176

Delayed Quote London Stock Exchange, September 29, 2023 at 03:40 am EDT

More quotes
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (96.9%). Net sales break down by treatment area between oncology (34%), cardiovascular, renal and metabolic diseases (21.4%), respiratory and autoimmune diseases (13.4%), and other (31.2%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (3.1%). Net sales are distributed geographically as follows: the United Kingdom (7%), Europe (20.1%), Americas (44.2%) and Africa/Asia/Australia (28.7%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
134.33USD
Average target price
170.39USD
Spread / Average Target
+26.84%
Consensus
1st Jan change Capi. (M$)
-0.48% 208 B $
+12.45% 212 B $
-13.43% 220 B $
-37.37% 181 B $
-5.99% 265 B $
-5.79% 269 B $
+3.11% 145 B $
+11.73% 133 B $
-19.19% 121 B $
-12.15% 93 974 M $
Other Pharmaceuticals
  1. Markets
  2. Equities
  3. Stock AstraZeneca PLC - London Stock Exchange
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer